Monday, May 27, 2024

Biogen and Ionis Pharma shares slide as they end development of ALS treatment

Must read




The move comes after early-stage trial failed to result in a clear signal it slowed the disease process.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article